About InfeXn
InfeXn is a Healthcare company based in Thane (India) founded in 2013. Specialized infectious disease testing and diagnostic services in India. The company has 129 employees. Its Indian entity Infexn Laboratories Private Limited reported revenue of ₹25.35 Cr. InfeXn offers products and services including Infectious Disease Testing and Environmental Surveillance. Its focus areas include Medical Diagnostics, Infectious Disease Testing, Pathogen Detection and Environmental Services.
Company details
InfeXn Laboratories is recognized as a specialized infectious disease testing facility that provides comprehensive diagnosis and interpretation services for various pathogens. A wide array of syndromic multiplex panels and molecular tests for over 200 pathogens is offered, along with tuberculosis testing and environmental surveillance. The laboratory is equipped with a BSL-3 containment area and utilizes advanced technologies like real-time PCR and gene sequencing. Certifications such as ISO 9001:2008 and NABL accreditation are maintained, ensuring reliable diagnostic support for healthcare needs.
- Headquarters Thane, India
- Employees 129
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website infexn.in
- Social LinkedIn Facebook Instagram
- Legal Name Infexn Laboratories Private Limited
- Date of Incorporation 28 Mar, 2013
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹25.35 Cr
FY 2024 · +8% YoY
- Net Profit₹2.5 Lakh
FY 2024 · 0% margin
- EBITDA₹1.64 Cr
FY 2024 · 6% margin
- Employee Count129
Associated legal entities of InfeXn
InfeXn operates through Infexn Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Infexn Laboratories Private Limited CIN U74999MH2013PTC241460 | Active | 28 Mar 2013 | Mumbai, Maharashtra | ₹25.3 Cr | 129 | 3 | View details |
Products & Services of InfeXn
InfeXn offers a comprehensive portfolio of products and services, including Infectious Disease Testing and Environmental Surveillance.
Testing for infectious diseases is performed through molecular and serological methods
Surveillance of disinfection and sterilization procedures is carried out in hospitals and clinics
Board of directors of Infexn Laboratories Private Limited (InfeXn)
Infexn Laboratories Private Limited is the primary company behind InfeXn. The board of Infexn Laboratories Private Limited currently have 3 directors; the longest-serving is Sachin Baliram Bhole, appointed in 2013. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sachin Baliram Bhole DIN 03538604 | Director | 28 Mar 2013 | 13 yrs 7 mo | Infexn Laboratories Private Limited |
| Anil Nanu Nair DIN 03537681 | Director | 28 Mar 2013 | 13 yrs 7 mo | Infexn Laboratories Private Limited |
| Sonal Rajesh Bangde DIN 06495382 | Director | 28 Mar 2013 | 13 yrs 7 mo | Infexn Laboratories Private Limited |
People of InfeXn
3 people are tracked at InfeXn (2 in leadership, 1 in team); the tracked headcount is 129.
| Name | Role | Group |
|---|---|---|
| CEO and Managing Director | Leadership | |
Dr Sonal Bangde | Founder & Medical Director | Leadership |
Masoom Siddiqui | Regional Sales Manager | Team |
Complete people profiles for InfeXn
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of InfeXn
Figures of Infexn Laboratories Private Limited, the primary company behind InfeXn, for FY 2024. Revenue was ₹25.35 Cr (+8% year on year). Net profit was ₹2.5 Lakh (0% margin). EBITDA was ₹1.64 Cr (6% margin). Revenue has grown at a compounded annual rate of -29% over three years and +38% over five years.
- ₹25.35 CrRevenue · FY 2024 · +8% YoY
- ₹2.5 LakhNet profit · 0% margin
- ₹1.64 CrEBITDA · 6% margin
- ₹10 LakhPaid-up capital
- 129Employees (provident fund records)
- -29%Revenue CAGR, 3 years
- +38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Infexn Laboratories Private Limited are on its company page.
Detailed financial statements for InfeXn
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about InfeXn
InfeXn was founded in 2013.
InfeXn is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
InfeXn has 129 employees.
The primary company behind InfeXn, Infexn Laboratories Private Limited, reported revenue of ₹25.35 Cr for FY 2024, up 8% year on year.
InfeXn Laboratories is recognized as a specialized infectious disease testing facility that provides comprehensive diagnosis and interpretation services for various pathogens. A wide array of syndromic multiplex panels and molecular tests for over 200 pathogens is offered, along with tuberculosis testing and environmental surveillance. The laboratory is equipped with a BSL-3 containment area and utilizes advanced technologies like real-time PCR and gene sequencing. Certifications such as ISO 9001:2008 and NABL accreditation are maintained, ensuring reliable diagnostic support for healthcare needs.
InfeXn offers Infectious Disease Testing and Environmental Surveillance.
InfeXn operates through Infexn Laboratories Private Limited.
The legal entities of InfeXn currently have 3 directors, including Sachin Baliram Bhole, Anil Nanu Nair, Sonal Rajesh Bangde.